Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 674

1.

Lung disease severity in idiopathic pulmonary fibrosis is more strongly associated with impedance measures of bolus reflux than pH parameters of acid reflux alone.

Gavini S, Borges LF, Finn RT, Lo WK, Goldberg HJ, Burakoff R, Feldman N, Chan WW.

Neurogastroenterol Motil. 2016 Dec 16. doi: 10.1111/nmo.13001. [Epub ahead of print]

PMID:
27987250
2.

Palbociclib and Letrozole in Advanced Breast Cancer.

Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Diéras V, Slamon DJ.

N Engl J Med. 2016 Nov 17;375(20):1925-1936.

3.

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators..

Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9.

PMID:
27932229
4.

The role of liver biopsy in hepatocellular carcinoma.

Finn RS.

Clin Adv Hematol Oncol. 2016 Oct;14(10):759-761. No abstract available.

PMID:
27930626
5.

Novel second-line treatments for hepatocellular carcinoma: Discussion.

Frenette CT, Lencioni R, Finn RS.

Clin Adv Hematol Oncol. 2016 Dec;14 Suppl 12(12):12-13. No abstract available.

PMID:
27930619
6.

Developing a treatment plan for hepatocellular carcinoma: the continuum of care.

Finn RS.

Clin Adv Hematol Oncol. 2016 Dec;14 Suppl 12(12):9-11. No abstract available.

PMID:
27930618
7.

The Role of Liver Biopsy in Hepatocellular Carcinoma.

Finn RS.

Gastroenterol Hepatol (N Y). 2016 Oct;12(10):628-630. No abstract available.

8.

InterPro in 2017-beyond protein family and domain annotations.

Finn RD, Attwood TK, Babbitt PC, Bateman A, Bork P, Bridge AJ, Chang HY, Dosztányi Z, El-Gebali S, Fraser M, Gough J, Haft D, Holliday GL, Huang H, Huang X, Letunic I, Lopez R, Lu S, Marchler-Bauer A, Mi H, Mistry J, Natale DA, Necci M, Nuka G, Orengo CA, Park Y, Pesseat S, Piovesan D, Potter SC, Rawlings ND, Redaschi N, Richardson L, Rivoire C, Sangrador-Vegas A, Sigrist C, Sillitoe I, Smithers B, Squizzato S, Sutton G, Thanki N, Thomas PD, Tosatto SC, Wu CH, Xenarios I, Yeh LS, Young SY, Mitchell AL.

Nucleic Acids Res. 2017 Jan 4;45(D1):D190-D199. doi: 10.1093/nar/gkw1107.

9.

Problems and complications of full-face carbon dioxide laser resurfacing for pathological lesions of the skin.

Read-Fuller AM, Yates DM, Vu DD, Hoopman JE, Finn RA.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jan;123(1):e10-e15. doi: 10.1016/j.oooo.2016.08.012.

PMID:
27727108
10.

Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.

Shi Y, Daniels-Wells TR, Frost P, Lee J, Finn RS, Bardeleben C, Penichet ML, Jung ME, Gera J, Lichtenstein A.

Cancer Res. 2016 Oct 1;76(19):5822-5831.

PMID:
27530328
11.

Maximum Quantity of Bone Available for Harvest From the Anterior Iliac Crest, Posterior Iliac Crest, and Proximal Tibia Using a Standardized Surgical Approach: A Cadaveric Study.

Burk T, Del Valle J, Finn RA, Phillips C.

J Oral Maxillofac Surg. 2016 Dec;74(12):2532-2548. doi: 10.1016/j.joms.2016.06.191.

PMID:
27524516
12.

Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection.

Zhang B, Finn RS.

Liver Cancer. 2016 Jul;5(3):221-32. doi: 10.1159/000367763. Review.

13.

Molecular and functional characterization of Bemisia tabaci aquaporins reveals the water channel diversity of hemipteran insects.

Van Ekert E, Chauvigné F, Finn RN, Mathew LG, Hull JJ, Cerdà J, Fabrick JA.

Insect Biochem Mol Biol. 2016 Oct;77:39-51. doi: 10.1016/j.ibmb.2016.07.010.

PMID:
27491441
14.

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.

Finn RS, Crown JP, Ettl J, Schmidt M, Bondarenko IM, Lang I, Pinter T, Boer K, Patel R, Randolph S, Kim ST, Huang X, Schnell P, Nadanaciva S, Bartlett CH, Slamon DJ.

Breast Cancer Res. 2016 Jun 28;18(1):67. doi: 10.1186/s13058-016-0721-5.

15.

Auto-Adhesion Potential of Extraocular Aqp0 during Teleost Development.

Chauvigné F, Fjelldal PG, Cerdà J, Finn RN.

PLoS One. 2016 May 6;11(5):e0154592. doi: 10.1371/journal.pone.0154592.

16.

Treatment of Intermediate-Stage Hepatocellular Carcinoma.

Finn RS.

Gastroenterol Hepatol (N Y). 2015 Aug;11(8):545-7. No abstract available.

17.

Unilateral Pleural Effusions with More Than One Apparent Etiology. A Prospective Observational Study.

Bintcliffe OJ, Hooper CE, Rider IJ, Finn RS, Morley AJ, Zahan-Evans N, Harvey JE, Skyrme-Jones AP, Maskell NA.

Ann Am Thorac Soc. 2016 Jul;13(7):1050-6. doi: 10.1513/AnnalsATS.201601-082OC.

PMID:
27064965
18.

Cache Domains That are Homologous to, but Different from PAS Domains Comprise the Largest Superfamily of Extracellular Sensors in Prokaryotes.

Upadhyay AA, Fleetwood AD, Adebali O, Finn RD, Zhulin IB.

PLoS Comput Biol. 2016 Apr 6;12(4):e1004862. doi: 10.1371/journal.pcbi.1004862.

19.

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.

Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, Ashcroft FM, Hattersley AT.

Diabetologia. 2016 Jun;59(6):1162-6. doi: 10.1007/s00125-016-3921-8.

20.

Treating cancer with selective CDK4/6 inhibitors.

O'Leary B, Finn RS, Turner NC.

Nat Rev Clin Oncol. 2016 Jul;13(7):417-30. doi: 10.1038/nrclinonc.2016.26. Review.

PMID:
27030077
Items per page

Supplemental Content

Support Center